Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachariah DeFilipp

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Blood|September 12, 2022
Effective treatment of low-risk acute GVHD with itacitinib monotherapyAaron Etra, Alexandra Capellini, Amin Alousi, et al.
Transplantation and Cellular Therapy|February 17, 2025
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice GuidelinesPashna N Munshi, Rebecca L Olin, Sarah Wall, et al.
Transplantation and Cellular Therapy|September 23, 2020
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular TherapyBhagirathbhai Dholaria, Bipin N Savani, Betty K Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host DiseaseCorey Cutler, Haesook T Kim, Hassan El Banna, et al.
Transplantation and Cellular Therapy|December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk GroupNikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Transplantation and Cellular Therapy|June 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD ReportZachariah DeFilipp, Daniel R Couriel, Aleksandr Lazaryan, et al.
Transplantation and Cellular Therapy|September 2, 2021
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host DiseaseMakda Getachew Zewde, George Morales, Isha Gandhi, et al.
Transplantation and Cellular Therapy|July 21, 2022
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2018
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant SurvivorsShahrukh K Hashmi, Stephanie J Lee, Bipin N Savani, et al.
Blood Advances|October 5, 2019
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancyScott R Solomon, Andrew St Martin, Nirav N Shah, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Blood|September 12, 2022
Effective treatment of low-risk acute GVHD with itacitinib monotherapyAaron Etra, Alexandra Capellini, Amin Alousi, et al.
Transplantation and Cellular Therapy|February 17, 2025
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice GuidelinesPashna N Munshi, Rebecca L Olin, Sarah Wall, et al.
Transplantation and Cellular Therapy|September 23, 2020
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular TherapyBhagirathbhai Dholaria, Bipin N Savani, Betty K Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host DiseaseCorey Cutler, Haesook T Kim, Hassan El Banna, et al.
Transplantation and Cellular Therapy|December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk GroupNikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Transplantation and Cellular Therapy|June 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD ReportZachariah DeFilipp, Daniel R Couriel, Aleksandr Lazaryan, et al.
Transplantation and Cellular Therapy|September 2, 2021
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host DiseaseMakda Getachew Zewde, George Morales, Isha Gandhi, et al.
Transplantation and Cellular Therapy|July 21, 2022
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2018
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant SurvivorsShahrukh K Hashmi, Stephanie J Lee, Bipin N Savani, et al.
Blood Advances|October 5, 2019
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancyScott R Solomon, Andrew St Martin, Nirav N Shah, et al.
Pageof 15